These findings collectively delineate the cell-type-specific regulatory landscape mediated by IKZF1, highlighting the necessity for context-dependent therapeutic approaches when targeting this transcription factor in pathological conditions beyond acute peritonitis. The gene discussed is IKZF1; the disease is peritonitis.